These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 37047826)
1. RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma. Kahm YJ; Kim IG; Kim RK Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047826 [TBL] [Abstract][Full Text] [Related]
2. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062 [TBL] [Abstract][Full Text] [Related]
3. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p. Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145 [TBL] [Abstract][Full Text] [Related]
4. Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2. Kahm YJ; Kim IG; Kim RK BMC Cancer; 2024 Mar; 24(1):319. PubMed ID: 38454443 [TBL] [Abstract][Full Text] [Related]
5. Impact of KIF4A on Cancer Stem Cells and EMT in Lung Cancer and Glioma. Kahm YJ; Kim IG; Jung U; Lee JH; Kim RK Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067227 [TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks. De A; Beligala DH; Sharma VP; Burgos CA; Lee AM; Geusz ME Clin Exp Metastasis; 2020 Oct; 37(5):617-635. PubMed ID: 32816185 [TBL] [Abstract][Full Text] [Related]
7. BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells. Kahm YJ; Kim RK Biochem Biophys Res Commun; 2023 Nov; 682():141-147. PubMed ID: 37806253 [TBL] [Abstract][Full Text] [Related]
8. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition. Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987 [TBL] [Abstract][Full Text] [Related]
9. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462 [TBL] [Abstract][Full Text] [Related]
10. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis. Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015 [TBL] [Abstract][Full Text] [Related]
11. HIF-1α induces the epithelial-mesenchymal transition in gastric cancer stem cells through the Snail pathway. Yang SW; Zhang ZG; Hao YX; Zhao YL; Qian F; Shi Y; Li PA; Liu CY; Yu PW Oncotarget; 2017 Feb; 8(6):9535-9545. PubMed ID: 28076840 [TBL] [Abstract][Full Text] [Related]
12. Role of microRNAs in the regulation of breast cancer stem cells. Liu S; Clouthier SG; Wicha MS J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423 [TBL] [Abstract][Full Text] [Related]
13. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells. Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro. Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460 [TBL] [Abstract][Full Text] [Related]
15. TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma. Chen L; Li YC; Wu L; Yu GT; Zhang WF; Huang CF; Sun ZJ J Cell Mol Med; 2018 Feb; 22(2):1337-1349. PubMed ID: 29193723 [TBL] [Abstract][Full Text] [Related]
16. APBB1 reinforces cancer stem cell and epithelial-to-mesenchymal transition by regulating the IGF1R signaling pathway in non-small-cell lung cancer cells. Lee JH; Kim JY; Kim SY; Choi SI; Kim KC; Cho EW; Kim IG Biochem Biophys Res Commun; 2017 Jan; 482(1):35-42. PubMed ID: 27836546 [TBL] [Abstract][Full Text] [Related]
17. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation. Markopoulos GS; Roupakia E; Marcu KB; Kolettas E Cells; 2019 Sep; 8(10):. PubMed ID: 31557902 [TBL] [Abstract][Full Text] [Related]
19. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells. Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731 [TBL] [Abstract][Full Text] [Related]
20. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation. Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]